GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (LTS:0NZY) » Definitions » EV-to-EBITDA

Eckert & Ziegler SE (LTS:0NZY) EV-to-EBITDA : 12.98 (As of Dec. 14, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Eckert & Ziegler SE EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Eckert & Ziegler SE's enterprise value is €909.4 Mil. Eckert & Ziegler SE's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was €70.1 Mil. Therefore, Eckert & Ziegler SE's EV-to-EBITDA for today is 12.98.

The historical rank and industry rank for Eckert & Ziegler SE's EV-to-EBITDA or its related term are showing as below:

LTS:0NZY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.71   Med: 11.23   Max: 47.09
Current: 12.99

During the past 13 years, the highest EV-to-EBITDA of Eckert & Ziegler SE was 47.09. The lowest was 2.71. And the median was 11.23.

LTS:0NZY's EV-to-EBITDA is ranked better than
60.21% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 16.095 vs LTS:0NZY: 12.99

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-14), Eckert & Ziegler SE's stock price is €46.18. Eckert & Ziegler SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €1.420. Therefore, Eckert & Ziegler SE's PE Ratio (TTM) for today is 32.52.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Eckert & Ziegler SE EV-to-EBITDA Historical Data

The historical data trend for Eckert & Ziegler SE's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE EV-to-EBITDA Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.05 17.78 29.71 14.48 12.84

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 12.84 10.72 12.02 11.41

Competitive Comparison of Eckert & Ziegler SE's EV-to-EBITDA

For the Medical Devices subindustry, Eckert & Ziegler SE's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's EV-to-EBITDA falls into.



Eckert & Ziegler SE EV-to-EBITDA Calculation

Eckert & Ziegler SE's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=909.431/70.057
=12.98

Eckert & Ziegler SE's current Enterprise Value is €909.4 Mil.
Eckert & Ziegler SE's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €70.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE  (LTS:0NZY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Eckert & Ziegler SE's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=46.18/1.420
=32.52

Eckert & Ziegler SE's share price for today is €46.18.
Eckert & Ziegler SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Eckert & Ziegler SE EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines